Piramal Pharma Ltd.
PPLPHARMAHealthcareR1 raw held document library
Coverage
| Dataset | On disk | Usable | State |
|---|---|---|---|
| Results XBRL (NSE + BSE) | 34 | 16 | 16 quarter-ends |
| Annual reports | 4 | 4 | identity graded |
| Earnings calls | 14 | 4 | transcripts and analyst meets only |
| Shareholding | 18 | 18 | |
| Related party | 5 | 5 | |
| Investor decks | 0 | 0 | cohort of 48 companies only |
Financial statements in parse — expected 19 Sep 2026. Nothing from the superseded legacy store is shown.
Earnings calls
14 transcript(s)/analyst meet(s) served; 10 document(s) on file are not transcripts (cover letters, duplicates, unresolved) and are excluded. Speaker attribution is shown only where the segmenter attributes ≥ 95% of sentences to management or analysts (0 of 14 documents here); elsewhere sentences render unattributed.
| Kind | Date | Period | Served | Attribution rate |
|---|---|---|---|---|
| TRANSCRIPT | 20221111 | 2022-09-30 | yes | |
| TRANSCRIPT | 20230213 | 2022-12-31 | yes | |
| TRANSCRIPT | 20230518 | 2023-03-31 | yes | |
| COVER_LETTER | 20230529 | 2023-03-31 | no | |
| TRANSCRIPT | 20230807 | 2023-06-30 | yes | |
| COVER_LETTER | 20231031 | 2023-09-30 | no | |
| COVER_LETTER | 20240202 | 2023-12-31 | no | |
| COVER_LETTER | 20240514 | 2024-03-31 | no | |
| COVER_LETTER | 20240729 | 2024-06-30 | no | |
| COVER_LETTER | 20241026 | 2024-09-30 | no | |
| COVER_LETTER | 20250130 | 2024-12-31 | no | |
| COVER_LETTER | 20251107 | 2025-09-30 | no | |
| COVER_LETTER | 20260130 | 2025-12-31 | no | |
| COVER_LETTER | 20260731 | 2026-06-30 | no |